VYGR
Price:
$4.35
Market Cap:
$241.84M
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosci...[Read more]
Industry
Biotechnology
IPO Date
2015-11-11
Stock Exchange
NASDAQ
Ticker
VYGR
According to Voyager Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.00. This represents a change of 2.56% compared to the average of -1.95 of the last 4 quarters.
The mean historical PE Ratio of Voyager Therapeutics, Inc. over the last ten years is -3.47. The current -2.00 PE Ratio has changed 5.66% with respect to the historical average. Over the past ten years (40 quarters), VYGR's PE Ratio was at its highest in in the June 2019 quarter at 22.91. The PE Ratio was at its lowest in in the December 2015 quarter at -18.74.
Average
-3.47
Median
-4.22
Minimum
-12.26
Maximum
7.23
Discovering the peaks and valleys of Voyager Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 259.24%
Maximum Annual PE Ratio = 7.23
Minimum Annual Increase = -283.33%
Minimum Annual PE Ratio = -12.26
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -5.03 | -283.33% |
| 2023 | 2.74 | -154.42% |
| 2022 | -5.04 | 226.12% |
| 2021 | -1.55 | -121.39% |
| 2020 | 7.23 | -158.92% |
| 2019 | -12.26 | 259.24% |
| 2018 | -3.41 | -45.75% |
| 2017 | -6.29 | -21.53% |
| 2016 | -8.02 | 159.27% |
| 2015 | -3.09 | -80.67% |
The current PE Ratio of Voyager Therapeutics, Inc. (VYGR) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.44
5-year avg
-0.33
10-year avg
-3.47
Voyager Therapeutics, Inc.’s PE Ratio is less than Atea Pharmaceuticals, Inc. (-1.90), greater than Entrada Therapeutics, Inc. (-4.07), greater than Humacyte, Inc. (-10.58), greater than Arcturus Therapeutics Holdings Inc. (-3.71), greater than Vanda Pharmaceuticals Inc. (-3.64), greater than Pyxis Oncology, Inc. (-2.78), greater than Achieve Life Sciences, Inc. (-4.66), greater than Enanta Pharmaceuticals, Inc. (-3.68), less than Allogene Therapeutics, Inc. (-1.51), greater than Sagimet Biosciences Inc. (-3.57),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.90 | $241.42M | |
| -4.07 | $388.31M | |
| -10.58 | $185.66M | |
| -3.71 | $185.27M | |
| -3.64 | $307.28M | |
| -2.78 | $268.92M | |
| -4.66 | $254.41M | |
| -3.68 | $300.59M | |
| -1.51 | $323.61M | |
| -3.57 | $196.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Voyager Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Voyager Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Voyager Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Voyager Therapeutics, Inc. (VYGR)?
What is the highest PE Ratio for Voyager Therapeutics, Inc. (VYGR)?
What is the 3-year average PE Ratio for Voyager Therapeutics, Inc. (VYGR)?
What is the 5-year average PE Ratio for Voyager Therapeutics, Inc. (VYGR)?
How does the current PE Ratio for Voyager Therapeutics, Inc. (VYGR) compare to its historical average?